Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 946627
[patent_doc_number] => 06964961
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-15
[patent_title] => 'Thiophene derivatives useful as anticancer agents'
[patent_app_type] => utility
[patent_app_number] => 09/873555
[patent_app_country] => US
[patent_app_date] => 2001-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25437
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/964/06964961.pdf
[firstpage_image] =>[orig_patent_app_number] => 09873555
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/873555 | Thiophene derivatives useful as anticancer agents | Jun 3, 2001 | Issued |
Array
(
[id] => 6225366
[patent_doc_number] => 20020004501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-10
[patent_title] => 'Heterocyclylalkylamines as muscarinic receptor antagonists'
[patent_app_type] => new
[patent_app_number] => 09/862286
[patent_app_country] => US
[patent_app_date] => 2001-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27977
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20020004501.pdf
[firstpage_image] =>[orig_patent_app_number] => 09862286
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/862286 | Heterocyclylalkylamines as muscarinic receptor antagonists | May 21, 2001 | Issued |
Array
(
[id] => 766432
[patent_doc_number] => 07008905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-07
[patent_title] => 'Method of combating undesired plant growth on cereals'
[patent_app_type] => utility
[patent_app_number] => 09/861006
[patent_app_country] => US
[patent_app_date] => 2001-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6069
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/008/07008905.pdf
[firstpage_image] =>[orig_patent_app_number] => 09861006
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/861006 | Method of combating undesired plant growth on cereals | May 17, 2001 | Issued |
Array
(
[id] => 5874772
[patent_doc_number] => 20020049203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'CRF receptor antagonists and methods relating thereto'
[patent_app_type] => new
[patent_app_number] => 09/861195
[patent_app_country] => US
[patent_app_date] => 2001-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11703
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20020049203.pdf
[firstpage_image] =>[orig_patent_app_number] => 09861195
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/861195 | CRF receptor antagonists and methods relating thereto | May 17, 2001 | Issued |
Array
(
[id] => 1298107
[patent_doc_number] => 06627628
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-30
[patent_title] => 'Substituted 4-amino-2-aryl-cyclopentadpyrimidines, their production and use and pharmaceutical preparations containing same'
[patent_app_type] => B1
[patent_app_number] => 09/856069
[patent_app_country] => US
[patent_app_date] => 2001-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9085
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 728
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/627/06627628.pdf
[firstpage_image] =>[orig_patent_app_number] => 09856069
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/856069 | Substituted 4-amino-2-aryl-cyclopentadpyrimidines, their production and use and pharmaceutical preparations containing same | May 16, 2001 | Issued |
Array
(
[id] => 6711625
[patent_doc_number] => 20030171374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'HIV replication inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/275931
[patent_app_country] => US
[patent_app_date] => 2002-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22624
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20030171374.pdf
[firstpage_image] =>[orig_patent_app_number] => 10275931
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/275931 | HIV replication inhibitors | May 2, 2001 | Issued |
Array
(
[id] => 1300079
[patent_doc_number] => 06624119
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-23
[patent_title] => '3-Benz(ox/thi)azol-7-yl-1h-pyrimidine-2,4-diones'
[patent_app_type] => B1
[patent_app_number] => 09/830961
[patent_app_country] => US
[patent_app_date] => 2001-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11702
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 370
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/624/06624119.pdf
[firstpage_image] =>[orig_patent_app_number] => 09830961
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/830961 | 3-Benz(ox/thi)azol-7-yl-1h-pyrimidine-2,4-diones | May 2, 2001 | Issued |
Array
(
[id] => 6730800
[patent_doc_number] => 20030186990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Prodrugs of hiv replication inhibiting pyrimidines'
[patent_app_type] => new
[patent_app_number] => 10/275333
[patent_app_country] => US
[patent_app_date] => 2002-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16443
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186990.pdf
[firstpage_image] =>[orig_patent_app_number] => 10275333
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/275333 | Prodrugs of HIV replication inhibiting pyrimidines | May 2, 2001 | Issued |
Array
(
[id] => 5802249
[patent_doc_number] => 20020010183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/847749
[patent_app_country] => US
[patent_app_date] => 2001-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35022
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20020010183.pdf
[firstpage_image] =>[orig_patent_app_number] => 09847749
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/847749 | Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors | May 1, 2001 | Issued |
Array
(
[id] => 1356354
[patent_doc_number] => 06576657
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-06-10
[patent_title] => 'Amidino derivatives and their use as thrombin inhibitors'
[patent_app_type] => B2
[patent_app_number] => 09/844428
[patent_app_country] => US
[patent_app_date] => 2001-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30628
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 676
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/576/06576657.pdf
[firstpage_image] =>[orig_patent_app_number] => 09844428
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/844428 | Amidino derivatives and their use as thrombin inhibitors | Apr 29, 2001 | Issued |
Array
(
[id] => 6861712
[patent_doc_number] => 20030092720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Drug efflux pump inhibitor'
[patent_app_type] => new
[patent_app_number] => 09/842234
[patent_app_country] => US
[patent_app_date] => 2001-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76215
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092720.pdf
[firstpage_image] =>[orig_patent_app_number] => 09842234
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/842234 | Drug efflux pump inhibitor | Apr 25, 2001 | Issued |
Array
(
[id] => 6474108
[patent_doc_number] => 20020151544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Fused heteroaryl derivatives'
[patent_app_type] => new
[patent_app_number] => 09/843615
[patent_app_country] => US
[patent_app_date] => 2001-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24381
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20020151544.pdf
[firstpage_image] =>[orig_patent_app_number] => 09843615
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/843615 | Fused heteroaryl derivatives | Apr 25, 2001 | Issued |
Array
(
[id] => 6852108
[patent_doc_number] => 20030144311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Propanoic acid derivatives as intergrin receptor antagonists'
[patent_app_type] => new
[patent_app_number] => 10/258584
[patent_app_country] => US
[patent_app_date] => 2002-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23074
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20030144311.pdf
[firstpage_image] =>[orig_patent_app_number] => 10258584
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/258584 | Propanoic acid derivatives as intergrin receptor antagonists | Apr 18, 2001 | Issued |
Array
(
[id] => 6442278
[patent_doc_number] => 20020128476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Inhibitors of cysteine protease'
[patent_app_type] => new
[patent_app_number] => 09/836586
[patent_app_country] => US
[patent_app_date] => 2001-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37469
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20020128476.pdf
[firstpage_image] =>[orig_patent_app_number] => 09836586
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/836586 | Inhibitors of cysteine protease | Apr 16, 2001 | Abandoned |
Array
(
[id] => 1535007
[patent_doc_number] => 06489333
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-12-03
[patent_title] => 'Integrin antagonists'
[patent_app_type] => B2
[patent_app_number] => 09/828751
[patent_app_country] => US
[patent_app_date] => 2001-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 101454
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 3127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/489/06489333.pdf
[firstpage_image] =>[orig_patent_app_number] => 09828751
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/828751 | Integrin antagonists | Apr 8, 2001 | Issued |
Array
(
[id] => 972340
[patent_doc_number] => 06936725
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-30
[patent_title] => 'Photochromic compounds'
[patent_app_type] => utility
[patent_app_number] => 09/819705
[patent_app_country] => US
[patent_app_date] => 2001-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2504
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/936/06936725.pdf
[firstpage_image] =>[orig_patent_app_number] => 09819705
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/819705 | Photochromic compounds | Mar 28, 2001 | Issued |
Array
(
[id] => 6707021
[patent_doc_number] => 20030153755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinases'
[patent_app_type] => new
[patent_app_number] => 10/239941
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7158
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20030153755.pdf
[firstpage_image] =>[orig_patent_app_number] => 10239941
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/239941 | Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinases | Mar 28, 2001 | Issued |
Array
(
[id] => 1575287
[patent_doc_number] => 06469028
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-22
[patent_title] => 'Synthesis and use of retinoid compounds having negative hormone and/or anatgonist activities'
[patent_app_type] => B1
[patent_app_number] => 09/821673
[patent_app_country] => US
[patent_app_date] => 2001-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 20
[patent_no_of_words] => 65281
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 508
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/469/06469028.pdf
[firstpage_image] =>[orig_patent_app_number] => 09821673
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/821673 | Synthesis and use of retinoid compounds having negative hormone and/or anatgonist activities | Mar 27, 2001 | Issued |
Array
(
[id] => 1005469
[patent_doc_number] => 06906065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-06-14
[patent_title] => '4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases'
[patent_app_type] => utility
[patent_app_number] => 10/239790
[patent_app_country] => US
[patent_app_date] => 2001-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11881
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/906/06906065.pdf
[firstpage_image] =>[orig_patent_app_number] => 10239790
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/239790 | 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases | Mar 22, 2001 | Issued |
Array
(
[id] => 6730814
[patent_doc_number] => 20030187004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => '2-Amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/221598
[patent_app_country] => US
[patent_app_date] => 2002-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8916
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20030187004.pdf
[firstpage_image] =>[orig_patent_app_number] => 10221598
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/221598 | 2-amino-3-(alkyl)-pyrimidone derivatives as GSK3.β.inhibitors | Mar 21, 2001 | Issued |